Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PFIZER LIMITED

Home Clinical Trial Sponsors and OrganizationsPFIZER LIMITED

PFIZER LIMITED

Ramsgate Road, Sandwich, United Kingdom

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

188

85 active

Approvals

278

Total approvals

Agencies

5

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

77

41.0%

Phase 2

37

19.7%

Phase 1

20

10.6%

Phase 4

9

4.8%

Phase 2/3

4

2.1%

Not Applicable

3

1.6%

Phase 3 4

3

1.6%

Phase 1/2

1

0.5%

Unknown

1

0.5%

Trial Status Distribution

Active, not recruiting

60

31.9%

Completed

65

34.6%

Not yet recruiting

25

13.3%

Recruiting

10

5.3%

Unknown

28

14.9%

Clinical Trials

Trials sponsored by this organization (188)

A study to find out if the medicine called rimegepant is safe for adults in India, who had side effects or did not feel better after taking other migraine medicines called triptans or cannot take it due to their medical condition

Active, not recruiting

Jul 202660 participants

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection

Not yet recruiting

Dec 202448 participants

A prospective study across 10 centers to evaluate persistence on treatment with advanced therapies in rheumatoid arthritis management in routine clinical practice.

Not yet recruiting

Sep 2024225 participants

Scientific data review of prostate cancer patients to study treatment patterns and understand need gaps.

Not yet recruiting

Aug 2024950 participants

A bioequivalence study of Prazosin Hydrochloride tablets 5 mg in healthy human adult subjects under fasting conditions

Jun 202236 participants

A Study to Determine the Effect of Aztreonam-Avibactam Versus Meropenem for the Treatment of Serious Infections Due to Gram Negative Bacteria.

Aug 2021425 participants

A Study to Determine the Effect of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Resistant (MBL-producing) Gram Negative Bacteria.

Jul 202060 participants

Study of Palbociclib taken together with letrozole for treatment of Post-Menopausal Women with Advanced Breast Cancer

Mar 2017300 participants

Page 1 of 24

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

8

Approvals

EMA

European Medicines Agency

3

Approvals

EMC

Electronic Medicines Compendium

232

Approvals

SFDA

Saudi Food and Drug Authority

9

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

26

Approvals

Recent Approvals

Bosulif 100 mg Hard Capsules

Bosulif 50 mg Hard Capsules

Voriconazole 40 mg/ml powder for oral suspension

MERONEM 500MG VIAL I-V

News

No news articles found

On this page

Overview
Clinical Trials188
Approvals278
News

Back to Organizations